Alpha Crest Capital Management LLC Jazz Pharmaceuticals PLC Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $1.4 Million - $1.79 Million	11,089 Added 142.66%	18,862 $2.51 Million
Q2 2022 Aug 11, 2022	BUY	$141.59 - $168.66 $1.1 Million - $1.31 Million	7,773 New	7,773 $1.21 Million
Q1 2022 May 12, 2022	SELL	$129.64 - $160.7 $2.29 Million - $2.83 Million	-17,631 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$119.87 - $145.67 $592,397 - $719,901	4,942 Added 38.95%	17,631 $2.25 Million
Q3 2021 Nov 10, 2021	BUY	$128.64 - $184.79 $988,469 - $1.42 Million	7,684 Added 153.53%	12,689 $1.65 Million
Q2 2021 Aug 12, 2021	SELL	$160.2 - $186.42 $51,904 - $60,400	-324 Reduced 6.08%	5,005 $889,000
Q1 2021 May 13, 2021	BUY	$150.19 - $173.5 $800,362 - $924,581	5,329 New	5,329 $876,000
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $574,546 - $785,220	-5,448 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$95.68 - $121.88 $837,008 - $1.07 Million	-8,748 Reduced 61.62%	5,448 $601,000
Q1 2020 May 13, 2020	BUY	$87.74 - $152.74 $606,283 - $1.06 Million	6,910 Added 94.84%	14,196 $1.42 Million
Q4 2019 Feb 12, 2020	SELL	$117.65 - $153.73 $1.21 Million - $1.58 Million	-10,260 Reduced 58.47%	7,286 $1.09 Million
Q3 2019 Nov 12, 2019	BUY	$125.18 - $143.24 $1.36 Million - $1.56 Million	10,903 Added 164.13%	17,546 $2.25 Million
Q2 2019 Aug 12, 2019	BUY	$125.55 - $144.48 $153,798 - $176,988	1,225 Added 22.61%	6,643 $947,000
Q1 2019 May 10, 2019	BUY	$121.81 - $142.95 $286,009 - $335,646	2,348 Added 76.48%	5,418 $775,000
Q4 2018 Feb 11, 2019	BUY	$115.94 - $166.74 $355,935 - $511,891	3,070 New	3,070 $381,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account